Artivion Inc at Deutsche Bank Leveraged Finance Conference Transcript
Good morning, everyone. I'm Ashley Lee, the CFO at Artivion, and joining me today is Josh Wells, our VP of Development.
Now before we get started, I just want to say that this presentation does contain forward-looking statements. So I wanted to maybe just to kind of give you a little bit of background on where we've been as an organization and kind of where we are, and where we're headed. Going back about 10 years ago, we had 2 main products. It was allograft tissue processing and BioGlue Surgical Adhesive. We were essentially an aortic company at that time. But as you can see that our addressable market opportunity was limited. We were profitable, and we were growing at the time. But we really didn't have an extended runway for growth.
And so right about that time is when our current CEO, Pat MacKin, joined the company. And one of the things that he did when he came in was first to assemble a management team. And he brought along with him several of his key executives from Medtronic, our Head of Sales, our General Counsel,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
